Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts

Journal of Infectious Diseases

Volumn 176, Issue 4, 1997, Pages 1072-1075

  LaRussa, Philip ^a   Steinberg, Sharon ^b   Meurice, François ^b   Gershon, Anne ^b  

^a College of Physicians and Surgeons ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; CHILD; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HERPES ZOSTER; HOUSEHOLD; HUMAN; LATEX AGGLUTINATION TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; SEROCONVERSION; SKIN CULTURE; VARICELLA ZOSTER VIRUS; VIRUS TRANSMISSION; VIRUS TYPING;

EID: 0030756296     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516514     Document Type: Article

References (18)

1. Williams V, Gershon A, Brunell P. Serologic response to varicella-zoster membrane antigens measured by indirect immunofluorescence. J Infect Dis 1974;130:669-72.
2. Steinberg S, Gershon A. Measurement of antibodies to varicella-zoster virus by using a latex agglutination test. J Clin Microbiol 1991;29: 1527-9.
3. LaRussa P, Steinberg S, Waithe E, Hanna B, Holzman R. Comparison of five assays for antibody to varicella-zoster virus and the fluorescent antibody to membrane antigen test. J Clin Microbiol 1987;25: 2059-62.
4. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg S, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 1992;66:1016-20.
5. LaRussa P, Steinberg S, Gershon A. Diagnosis and typing of varicella-zoster virus (VZV) in clinical specimens by polymerase chain reaction (PCR) [abstract 1486]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando, FL). Washington, DC: American Society for Microbiology, 1994.
6. Gershon AA, Steinberg S, Gelb L, NIAID Collaborative Varicella Vaccine Study Group. Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA 1984;252:355-62.
7. Gershon A, Steinberg S, Gelb L, NIAID Collaborative Varicella Vaccine Study Group. Live attenuated varicella vaccine: use in immunocompromised children and adults. Pediatrics 1986;78(suppl):757-62.
8. Tsolia M, Gershon A, Steinberg S, Gelb L. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. J Pediatr 1990;116: 184-9.
9. Gershon A. Varicella-zoster virus: prospects for control. Adv Pediatr Infect Dis 1995;10:93-124.
10. Weibel R, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus vaccine: efficacy trial in healthy children. N Engl J Med 1984;310:1409-15.
11. Committee on Infectious Diseases. Live attenuated varicella vaccine. Pediatrics 1995;95:93-124.
12. White CJ, Kuter BJ, Hildebrand CS, et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics 1991;87:604-10.
13. Gershon AA, Steinberg S, LaRussa P, Hammerschlag M, Ferrara A, NIAID Collaborative Varicella Vaccine Study Group. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis 1988;158: 132-7.
14. Gershon AA, Steinberg S, NIAID Collaborative Varicella Vaccine Study Group. Live attenuated varicella vaccine: protection in healthy adults in comparison to leukemie children. J Infect Dis 1990;161:661-6.
15. Varis T, Vesikari T. Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J Infect Dis 1996;174(suppl 3):S330-4.
16. Hughes P, LaRussa PS, Pearce JM, Lepow ML, Steinberg SP, Gershon A. Transmission of varicella-zoster virus from a vaccinee with underlying leukemia, demonstrated by polymerase chain reaction. J Pediatr 1994; 124:932-5.
17. LaRussa P, Steinberg S, Arvin A, et al. PCR and RFLP analysis of VZV isolates from the USA and other parts of the world [abstract 17]. In: 3rd International Conference on the Varicella-Zoster Virus (Palm Beach, Florida). New York: VZV Foundation, 1997.
18. LaRussa P, Steinberg S, Gershon A. Identification and differentiation of wild (WT)- and vaccine (OKA)-strain VZV isolates by PCR from recipients of live attenuated varicella vaccine (LAW) [abstract P-49]. In: 3rd International Conference on the Varicella-Zoster Virus (Palm Beach, Florida). New York: VZV Foundation, 1997.